|
TP53BP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.368500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.301380E-03 |
| Normal-vs-Stage2 |
2.373800E-02 |
| Normal-vs-Stage3 |
2.32510000000019E-05 |
| Normal-vs-Stage4 |
1.504970E-03 |
| Stage1-vs-Stage2 |
7.568400E-01 |
| Stage1-vs-Stage3 |
3.321600E-02 |
| Stage1-vs-Stage4 |
6.374600E-01 |
| Stage2-vs-Stage3 |
1.424750E-01 |
| Stage2-vs-Stage4 |
5.766200E-01 |
| Stage3-vs-Stage4 |
2.808400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.219500E-04 |
| Normal-vs-AfricanAmerican |
1.858850E-01 |
| Normal-vs-Asian |
8.713000E-01 |
| Caucasian-vs-AfricanAmerican |
1.006390E-02 |
| Caucasian-vs-Asian |
9.547800E-02 |
| AfricanAmerican-vs-Asian |
6.015200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.358940E-04 |
| Normal-vs-Female |
3.876900E-03 |
| Male-vs-Female |
1.038600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.358640E-01 |
| Normal-vs-Age(41-60Yrs) |
5.151800E-04 |
| Normal-vs-Age(61-80Yrs) |
3.849200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.871700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.217200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.995000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.843600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.517600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.593400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.298400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.126000E-01 |
| Normal-vs-Grade 2 |
1.221730E-03 |
| Normal-vs-Grade 3 |
6.32079999999258E-05 |
| Normal-vs-Grade 4 |
5.017400E-03 |
| Grade 1-vs-Grade 2 |
1.207220E-01 |
| Grade 1-vs-Grade 3 |
3.042000E-02 |
| Grade 1-vs-Grade 4 |
1.581810E-01 |
| Grade 2-vs-Grade 3 |
1.280570E-01 |
| Grade 2-vs-Grade 4 |
9.430600E-01 |
| Grade 3-vs-Grade 4 |
2.408600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.398660E-03 |
| Normal-vs-ccB subtype |
4.823700E-04 |
| ccA subtype-vs-ccB subtype |
5.143400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.377840E-04 |
| Normal-vs-N1 |
9.012200E-01 |
| N0-vs-N1 |
7.685800E-02 |
|
|
